Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -5.74% vs -22.68% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -50.51% vs -24.25% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "161.00",
          "val2": "170.80",
          "chgp": "-5.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.60",
          "val2": "65.50",
          "chgp": "-56.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.20",
          "val2": "3.30",
          "chgp": "118.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.10",
          "val2": "1.70",
          "chgp": "23.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.90",
          "val2": "58.40",
          "chgp": "-50.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "177.30%",
          "val2": "213.70%",
          "chgp": "-3.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -11.77% vs -5.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -31.36% vs -8.29% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "688.90",
          "val2": "780.80",
          "chgp": "-11.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "218.20",
          "val2": "289.30",
          "chgp": "-24.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "15.10",
          "val2": "25.00",
          "chgp": "-39.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.60",
          "val2": "0.30",
          "chgp": "1,433.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "174.70",
          "val2": "254.50",
          "chgp": "-31.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "165.00%",
          "val2": "242.50%",
          "chgp": "-7.75%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

161.00

170.80

-5.74%

Operating Profit (PBDIT) excl Other Income

28.60

65.50

-56.34%

Interest

7.20

3.30

118.18%

Exceptional Items

2.10

1.70

23.53%

Consolidate Net Profit

28.90

58.40

-50.51%

Operating Profit Margin (Excl OI)

177.30%

213.70%

-3.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -5.74% vs -22.68% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -50.51% vs -24.25% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

688.90

780.80

-11.77%

Operating Profit (PBDIT) excl Other Income

218.20

289.30

-24.58%

Interest

15.10

25.00

-39.60%

Exceptional Items

4.60

0.30

1,433.33%

Consolidate Net Profit

174.70

254.50

-31.36%

Operating Profit Margin (Excl OI)

165.00%

242.50%

-7.75%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -11.77% vs -5.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -31.36% vs -8.29% in Dec 2023

All Annual Results